Onderneming AstraZeneca Pharma India Limited NSE India S.E.
Aandelen
ASTRAZEN
INE203A01020
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.753 INR | -0,51% | +4,77% | +4,10% |
Vakgebied
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Tablets
75,2
%
| 6 491 | 80,6 % | 7 543 | 75,2 % | +16,21% |
Injectables
16,7
%
| 937 | 11,6 % | 1 674 | 16,7 % | +78,56% |
Clinical Trials
6,1
%
| 442 | 5,5 % | 612 | 6,1 % | +38,57% |
Inhalation
2,0
%
| 186 | 2,3 % | 201 | 2,0 % | +8,06% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
93,6
%
| 7 592 | 94,2 % | 9 389 | 93,6 % | +23,68% |
International
6,4
%
| 464 | 5,8 % | 641 | 6,4 % | +37,95% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Siva Padmanabhan
CEO | Chief Executive Officer | - | - |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 01-02-03 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 01-10-23 |
Anil Kukreja
CTO | Chief Tech/Sci/R&D Officer | - | - |
Manasa Rama
CMP | Compliance Officer | - | 11-08-22 |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 01-04-21 |
Pankaj Jain
LAW | General Counsel | - | - |
Rishi Kapur
LAW | General Counsel | - | - |
Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 65 | 02-12-16 |
Chairman | 67 | 06-12-12 | |
Director/Board Member | 50 | 29-12-21 | |
Ankush Nandra
BRD | Director/Board Member | 52 | 18-05-20 |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 01-02-03 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 01-10-23 |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 01-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 25 000 000 | 3 106 045 ( 12,42 %) | 0 | 12,42 % |
Bedrijfsgegevens
AstraZeneca Pharma India Ltd.
Manyata Embassy Business Park Outer Ring Road, Rachenahalli
560045, Bangalore
+91 80 6774 8000
http://www.astrazeneca.inSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 723 mld. | |
+31,33% | 598 mld. | |
-3,51% | 364 mld. | |
+19,94% | 331 mld. | |
+5,14% | 288 mld. | |
+15,92% | 244 mld. | |
+9,60% | 210 mld. | |
-4,99% | 208 mld. | |
+9,32% | 169 mld. |
- Beurs
- Aandelen
- Koers ASTRAZEN
- Koers ASTRAZEN
- Onderneming AstraZeneca Pharma India Limited